Abstract
To evaluate the mechanisms underlying prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation (SCT), an index for plasma glycocalicin normalized for the individual platelet count (GCI), plasma thrombopoietin (TPO), and circulating B cells producing anti-GPIIb-IIIa antibodies were measured in 50 SCT recipients with or without prolonged thrombocytopenia, 42 patients with idiopathic thrombocytopenic purpura, nine patients with aplastic anemia, and 22 healthy individuals. All three indices were significantly higher in the SCT recipients with thrombocytopenia than in those without (P<0.01 for all comparisons), and were significantly correlated with the platelet count in SCT recipients. Stepwise multiple regression analysis of the samples from the SCT recipients revealed that GCI and TPO independently pointed to specific mechanisms of thrombocytopenia. The GCI and TPO status in SCT recipients with thrombocytopenia had a pattern similar to that seen in aplastic anemia, suggesting a major role for impaired thrombopoiesis. An antiplatelet antibody response was frequently detected in SCT recipients, but the development of thrombocytopenia is likely to depend on additional factors, such as reticuloendothelial function. In summary, post transplant prolonged thrombocytopenia is associated with complex mechanisms, including impaired thrombopoiesis and increased platelet turnover.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
First LR, Smith BR, Lipton J, Nathan DG, Parkman R, Rappeport JM . Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood 1985; 65: 368–374.
Klumpp TR, Block CC, Caligiuri MA, Rabinowe SN, Soiffer RJ, Ritz J . Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature. Medicine (Baltimore) 1992; 71: 73–83.
Bruno B, Gooley T, Sullivan KM, Davis C, Bensinger WI, Storb R et al. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 154–162.
Dodds A . Hematologic complications. In: Atkinson K (ed). Clinical Bone Marrow and Blood Stem Cell Transplantation, 2nd edn. Cambridge University Press: UK, 2000, pp. 1038–1043.
Kottaridis PD, Rees H, Smith G, Gamer SF, Perry AR, Peniket AJ et al. A fatal case of autoimmune thrombocytopenia with an IgM anti-GPIb/IX following one antigen mismatched unrelated donor bone marrow transplantation. Bone Marrow Transplantation 1999; 23: 739–741.
Panzer S, Kiefel V, Bartram CR, Haas OA, Hinterberger W, Mueller-Eckhardt C et al. Immune thrombocytopenia more than a year after allogeneic marrow transplantation due to antibodies against donor platelets with anti-PlA1 specificity: evidence for a host-derived immune reaction. Br J Haematol 1989; 71: 259–264.
Bierling P, Pignon JM, Kuentz M, Mitjavila MT, Fromont P, Barbu V et al. Thrombocytopenia after bone marrow transplantation caused by a recipient origin Bra allo-antibody: presence of mixed chimerism 3 year after the graft without hematologic relapse. Blood 1994; 83: 274–279.
Beer JH, Buchi L, Steiner B . Glycocalicin: a new assay. The normal plasma levels and its potential usefulness in selected disease. Blood 1994; 83: 691–702.
Hou M, Andersson PO, Stockelberg D, Mellqvist UH, Ridell B, Wadenvik H . Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes. Br J Haematol 1998; 101: 420–424.
Schrezenmeier H, Griesshammer M, Hornkohl A, Nichol JL, Hecht T, Heimpel H et al. Thrombopoietin serum levels in patients with aplastic anemia: correlation with platelet count and persistent elevation in remission. Br J Haematol 1998; 100: 571–576.
Kurata Y, Hayashi S, Kiyoi T, Kosugi S, Kashiwagi H, Honda S et al. Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia. Am J Clin Pathol 2001; 115: 656–664.
van den Oudenrijn S, Bruin M, Folman CC, Bussel J, de Haas M, von dem Bome AE . Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia. Br J Haematol 2002; 117: 390–398.
Steinberg MH, Kelton JG, Coller BS . Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders. N Engl J Med 1987; 317: 1037–1042.
Kaushansky K . Thrombopoietin: a tool for understanding thrombopoiesis. J Thromb Haemost 2003; 1: 1587–1592.
Woods VL, Oh E, Mason D, McMillan R . Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic immune thrombocytopenic purpura. Blood 1984; 63: 368–375.
Kuwana M, Okazaki Y, Kaburaki J, Ikeda Y . Detection of circulating B cells secreting platelet-specific autoantibody is useful in the diagnosis of autoimmune thrombocytopenia. Am J Med 2003; 114: 322–325.
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
Cines DB, Blanchette VS . Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995–1008.
Guinan EC . Clinical aspects of aplastic anemia. Haematol/Oncol Clin N Am 1997; 11: 1025–1044.
Louwes H, Zeinali OA, Vollenga E, de Wolf JTM . Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura. Am J Med 1999; 106: 430–434.
Kuwana M, Okazaki Y, Sato T, Asahi A, Kajihara M, Ikeda Y . Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura. Am J Med 2005; 118: 1026–1033.
Hürlimann-Forster M, Steiner B, von Felten A . Quantitation of platelet-specific autoantibodies in platelet eluates of ITP patients measured by a novel ELISA using the purified glycoprotein complexes GPIIb/IIIa and GPIb/IX as antigens. Br J Haematol 1997; 98: 328–335.
Kuwana M, Okazaki Y, Kaburaki Y, Kawakami Y, Ikeda Y . Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J Immunol 2002; 168: 3675–3682.
McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K . Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995; 86: 3668–3675.
Sungaran R, Markovic B, Chong BH . Localisation and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization. Blood 1997; 89: 101–107.
Dominietto A, Raiola AM, Lint MT, Lamparelli T, Gualandi F, Berisso G et al. Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose. Br J Haematol 2001; 112: 219–227.
Anasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ . Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 1989; 73: 1054–1058.
Benda H, Panzer S, Kiefel V, Mannhalter C, Hinterberger W, Lechner K et al. Identification of the target platelet glycoprotein in autoimmune thrombocytopenia occurring after allogeneic bone marrow transplantation. Blut 1989; 58: 151–153.
Bierling P, Cordonnier C, Fromont P, Rodet M, Tanzer J, Vemant JP et al. Acquired autoimmune thrombocytopenia after allogeneic bone marrow transplantation. Br J Haematol 1985; 59: 643–646.
Acknowledgements
This work was supported by the Japanese Ministry of Health, Labour and Welfare. We thank the staff of the Keio BMT program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamazaki, R., Kuwana, M., Mori, T. et al. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant 38, 377–384 (2006). https://doi.org/10.1038/sj.bmt.1705444
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705444
Keywords
This article is cited by
-
What causes aplastic anaemia?
Leukemia (2023)
-
Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children
Bone Marrow Transplantation (2022)
-
Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience
Annals of Hematology (2022)
-
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation (2021)
-
Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation
Cellular & Molecular Immunology (2020)